The rise in the use of GLP-1 weight-loss drugs across the U.S. is shifting not only scales, but also how Americans are spending their time and money.
Breakdown
- GLP-1 drug use among US adults has doubled to over 12% in a year 10s
- Demand rises for smaller clothing sizes and healthier foods 1m 2s
- GLP-1 users report increased confidence and higher travel spending 1m 21s
- High drug costs remain a barrier, but cheaper options are expected 1m 39s
- Usage of GLP-1 drugs is expected to keep increasing as access grows 2m 10s